The company provides data center infrastructure services, including leasing and maintenance of storage facilities, and has recently diversified into road construction projects for national highways.
The company lacks a durable moat, as evidenced by a massive collapse in EPS and a sudden pivot from irrigation to data centers and highway construction. High ROCE is likely a function of a small, asset-light base during a transition phase rather than sustainable pricing power.
Management has shifted capital from legacy operations into unrelated high-capex fields like data centers and road construction. The issuance of equity at a massive premium to intrinsic value suggests opportunistic financing rather than disciplined reinvestment.
The company's pivot from irrigation to data centers and road construction proved to be a desperate attempt to outrun regulatory scrutiny rather than a strategic evolution. The Enforcement Directorate's asset freezes paralyzed operations, while the lack of verifiable trade receivables revealed that the reported revenue was largely illusory. As the disqualified Managing Director lost control and the board continued its exodus, the business collapsed under the weight of legal penalties and the realization that the high ROCE was merely a byproduct of an asset-light shell game rather than industrial competence.
RichFakir rates IKOMA Technologies Limited's business quality as poor — 37/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, IKOMA Technologies Limited is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on IKOMA Technologies Limited is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of IKOMA Technologies Limited's fair value is about ₹3 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →